Androgen Receptor, Control Peptide (AR, KD, AIS, TFM, DHTR, SBMA, NR3C4, SMAX1, HUMARA, androgen receptor (dihydrotestosterone receptor testicular feminization spinal and bulbar muscular atrophy Kennedy disease), dihydrotestosterone receptor)
Catalog No : USB-A2281-01B-P
421.85€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
| Product name | Androgen Receptor, Control Peptide (AR, KD, AIS, TFM, DHTR, SBMA, NR3C4, SMAX1, HUMARA, androgen receptor (dihydrotestosterone receptor testicular feminization spinal and bulbar muscular atrophy Kennedy disease), dihydrotestosterone receptor) | ||
|---|---|---|---|
| Catalog No | USB-A2281-01B-P | ||
| Supplier’s Catalog No | A2281-01B-P | ||
| Supplier | US Biologicals | ||
| Source antigen | Synthetic | ||
| Reactivity | |||
| Cross reactivity | |||
| Applications | |||
| Molecular weight | |||
| Storage | -20°C | ||
|---|---|---|---|
| Other names | |||
| Grade | Highly Purified | ||
| Purity | Supplied as a lyophilized powder in ddH2O, 5% (v/v) acetonitrile. Reconstitute with 200ul sterile ddH2O. | ||
| Form | |||
| Reactivity life | 12 months | ||
| Note | For reserch purpose only | ||
| Purity | Supplied as a lyophilized powder in ddH2O, 5% (v/v) acetonitrile. Reconstitute with 200ul sterile ddH2O. | ||
| Description | EVQLGLGRVYPRPPSC corresponding to the N Terminus of human Androgen Receptor. Control peptide to polyclonal antibody, Catalog# A2281-01B, goat x human. The androgen receptor (AR) is a member of the steroid superfamily of ligand-dependent transcription factors. The expression of AR is reportedly inversely correlated with histologic grade i.e. well differentiated prostate tumors show higher expression than the poorly differentiated tumors. In prostate cancer, AR has been proposed as a marker of hormone-responsiveness. Applications: Suitable for use in ELISA and Antibody Blocking. Other applications not tested. Recommended Dilutions: Optimal dilutions to be determined by the researcher. Storage and Stability: Lyophilized powder may be stored at -20°C. Stable for 6 months after receipt at -20°C. Reconstite with sterile dH2O. Aliquot to avoid repeated freezing and thawing. Store at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. Peptide Blocking (see corresponding antibody A2281-01B): Antibodies are typically supplied at 0.5mg/ml and peptides as a 100ug pellet. When peptides are reconstituted in 200ul water, the concentration will be 0.5mg/ml. To start, the best ratio would be 1:1 (which means molar excess of peptides relative to antibodies when identical volumes are mixed). Mix equal volumes of peptide and antibody at the required dilution and leave at ambient temperature. It is best is to have two identical blots, to be incubated with equal amount of antibodies, but one with the antibodies pre-adsorbed to the peptide for 20min. Then incubate and develop the two blots in parallel. | ||
© 2020 Imugex All Rights Reserved